Director, HTA, Value & Evidence (HV&E) - Lung Cancer

ROLE SUMMARY

As a leading biopharmaceutical company, Pfizer is dedicated to the discovery and delivery of high value therapies across a variety of disease areas. It is our mission to bring innovative medicines to patients that significantly improve their lives, and our priority is to ensure patients have access to these medicines.

The Health Technology Assessment (HTA), Value & Evidence (HV&E) team is responsible for ensuring patients have affordable, timely access to medicines and vaccines by advancing innovative value and evidence solutions to inform healthcare decision-making.

The Director, HTA, Value & Evidence (HV&E) – Lung Cancer will support the strategic goals of the Oncology Division by driving optimal patient access for Pfizer’s lung cancer portfolio.

This role influences global business objectives by guiding strategic evidence development to ensure optimal patient access for Lorbrena (lorlatinib). The HV&E Director will be responsible for developing and executing against the global evidence generation strategy, including direct oversight of evidence generation activities and dissemination of technical deliverables.

This position will be part of Pfizer’s dynamic Global Access & Value (GAV) team and will have the important role of managing health economics and outcomes research (HEOR) to generate data to support patient access to lorlatinib. This position will be working closely with the broader Thoracic & Precision Medicine GAV team, cross-functional (e.g., medical, clinical, commercial, etc.) and country teams to foster a culture that promotes innovation and thrives on doing better for Pfizer’s patients and society in general.

ROLE RESPONSIBILITIES

• Lead the development/execution of the evidence generation strategy to support the value of lung cancer assets as the lorlatinib global HV&E lead, in close partnership with the cross-functional matrix team (e.g., medical, commercial, access strategy/pricing, statistics, clinical).
• Lead the coordination of input from local country/regional teams on evidence needs and ensure that the input is appropriately incorporated into the evidence strategy to support global market access needs at launch and through lifecycle.
• Lead the design and execution of global HEOR studies (e.g., network meta-analyses, non-interventional studies, economic models) from concept through publication.  
• Lead the timely development of core deliverables including value & evidence strategy, global value dossiers/AMCP dossiers, systematic literature reviews, economic models, and innovative tools to successfully support reimbursement and access requirements in partnership with the regions/countries.
• Develop patient-reported outcomes strategy and incorporate humanistic and economic endpoints into clinical trials across all phases of product development to build comprehensive trial-based evidence aligned with overall asset strategy and to ensure global reimbursement and access requirements.
• Provide strategic input into clinical trial designs (eg, patient populations, comparators, endpoints) and analyses to enable successful negotiations, reimbursement, and appropriate patient access with global payer and regulatory decision makers.
• Partner with internal stakeholders to ensure appropriate customer facing dissemination of HEOR materials per regulatory guidance and internal SOPs.
• Develop strategic partnerships and research collaborations with key external experts, healthcare policy makers, payers, and various academic and community oncology settings to support asset strategies.

BASIC QUALIFICATIONS

Candidate demonstrates a breadth of diverse leadership experiences and capabilities including: the ability to influence and collaborate with peers, develop and coach others, oversee and guide the work of other colleagues to achieve meaningful outcomes and create business impact. 

• Graduate degree required (e.g. MSc, MPH, PhD, DrPH)
• 7+ years of experience with MSc/MPH/MBA degree; 5+ years with PharmD/PhD/DrPH in HEOR or relevant related fields (health economics, epidemiology, health services research, or other research-focused public health field)
• Expertise in HEOR strategy, evidence development, fundamental health services research methods and tools, including health economic modeling, patient-reported outcomes, statistics, and real-world evidence studies including technical and methodological aspects of registries and observational study design, implementation, analysis and interpretation.
• Capable of independently managing complex non-interventional study projects
• Knowledge and understanding of drug development process
• Excellent interpersonal skills required: ability to understand and respond to multiple internal and external customers
• Excellent oral and written English communication skills
• Demonstrated ability to assess anticipated value for projects/programs to ensure alignment to business priorities and prioritize accordingly
• An “execution mindset” focused on getting things done quickly and simply
• Strong project management abilities (contracting, budgeting, vendor management) essential. Demonstrated ability to manage multiple projects (multitask) involving complex processes, significant budget, competing deadlines and rapidly shifting priorities and expertise in stakeholder engagement
• Leadership in cross-functional teams (e.g. influence medical, clinical, and commercial teams constructively and without conflict); strategic thinking, and ability to guide junior team members
• Skilled in functioning within a matrix organization
• Organized and detail oriented with the ability to anticipate needs and to work proactively to prioritize & address/resolve
• Change oriented, comfortable responding to unexpected demands with tight timelines

PREFERRED QUALIFICATIONS

• Knowledge and experience in oncology or lung cancer
• Experience with HTA organizations such as NICE, CADTH, PBAC, ICER and other HTA groups
• Knowledge of industry trends (e.g. IPAY, EU HTA Regulation)
• Demonstrated publication history in venerable peer reviewed journals
• Experience in the biotech/pharmaceutical industry
• Experience in supporting a global oncology launch
• Experience leading retrospective cohort studies across various public and proprietary databases
• Experience in planning and executing a variety of real-world study designs (e.g., prospective/registries, cross-sectional, etc.)
• Ability to communicate technical and complex epidemiological and statistical concepts to various audiences
• Experience leveraging data from real-world to impact decision making

Other Job Details:

• Last Date to Apply for Job: September 22nd, 2025.
• Ability to travel based on business needs (25%)
• NOT eligible for Relocation Package
• This position is hybrid and requires working onsite 2 to 3 days per week

#LI-PFE

The annual base salary for this position ranges from $169,700.00 to $282,900.00. In addition, this position is eligible for participation in Pfizer’s Global Performance Plan with a bonus target of 20.0% of the base salary and eligibility to participate in our share based long term incentive program. We offer comprehensive and generous benefits and programs to help our colleagues lead healthy lives and to support each of life’s moments. Benefits offered include a 401(k) plan with Pfizer Matching Contributions and an additional Pfizer Retirement Savings Contribution, paid vacation, holiday and personal days, paid caregiver/parental and medical leave, and health benefits to include medical, prescription drug, dental and vision coverage. Learn more at Pfizer Candidate Site – U.S. Benefits | (uscandidates.mypfizerbenefits.com). Pfizer compensation structures and benefit packages are aligned based on the location of hire. The United States salary range provided does not apply to Tampa, FL or any location outside of the United States.

Relocation assistance may be available based on business needs and/or eligibility.

Market Access